Creso Pharma’s (ASX:CPH) goal is to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Creso’s New Immunity Boosting CBD Hemp Teas Set for Release
Mar 24, 2020
Creso Pharma Limited (ASX: CPH) is expanding its available product line with the release of a hemp tea in Q3 2020.
Canada Legalises Cannabis as CPH Moves Front and Centre With a 100% Owned Canadian Growing Facility
Oct 18, 2018
CPH Gets Green Light to Distribute its Innovative CBD Based Nutraceutical Products in the UK
Jan 18, 2018
CPH Seal Swiss Pharma Deal: Setting the Cornerstone for Global Commercialisation of cannaQIX
Dec 4, 2017
CPH to Acquire Canadian Cannabis Grower and Strengthen Position in Multi-Billion Dollar Market
Jul 27, 2017